Publication:
3-Pyridinylboronic acid normalizes the effects of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in zebrafish embryos

dc.contributor.authorALTURFAN, EBRU IŞIK
dc.contributor.authorMEGA TİBER, PINAR
dc.contributor.authorsUstundag, Fumet Duygu; Unal, Ismail; Cansiz, Derya; Ustundag, Unsal Veli; Subasat, Hulya Kara; Alturfan, A. Ata; Tiber, Pinar Mega; Emekli-Alturfan, Ebru
dc.date.accessioned2022-03-12T22:54:44Z
dc.date.accessioned2026-01-11T05:59:57Z
dc.date.available2022-03-12T22:54:44Z
dc.description.abstract1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that damages dopaminergic neurons. Zebrafish has been shown to be a suitable model organism to investigate the molecular pathways in the pathogenesis of Parkinson's disease and also for potential therapeutic agent research. Boron has been shown to play an important role in the neural activity of the brain. Boronic acids are used in combinatorial approaches in drug design and discovery. The effect of 3-pyridinylboronic acid which is an important sub-class of heterocyclic boronic acids has not been evaluated in case of MPTP exposure in zebrafish embryos. Accordingly, this study was designed to investigate the effects of 3-pyridinylboronic acid on MPTP exposed zebrafish embryos focusing on the molecular pathways related to neurodegeneration and apoptosis by RT-PCR. Zebrafish embryos were exposed to MPTP (800 mu M); MPTP + Low Dose 3-Pyridinylboronic acid (50 mu M) (MPTP + LB) and MPTP + High Dose 3-Pyridinylboronic acid (100 mu M) (MPTP + HB) in well plates for 72 hours post fertilization. Results of our study showed that MPTP induced a P53 dependent and Bax mediated apoptosis in zebrafish embryos and 3-pyridinylboronic acid restored the locomotor activity and gene expressions related to mitochondrial dysfunction and oxidative stress due to the deleterious effects of MPTP, in a dose-dependent manner.
dc.identifier.doi10.1080/01480545.2020.1795189
dc.identifier.eissn1525-6014
dc.identifier.issn0148-0545
dc.identifier.pubmed32693643
dc.identifier.urihttps://hdl.handle.net/11424/236499
dc.identifier.wosWOS:000550941000001
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofDRUG AND CHEMICAL TOXICOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject1-methyl-4-phenyl-1
dc.subject2
dc.subject3
dc.subject6-tetrahydropyridine
dc.subject3-pyridinylboronic acid
dc.subjectzebrafish embryo
dc.subjectneurodegeneration
dc.subjectapoptosis
dc.subjectPARKINSONS-DISEASE
dc.subjectBORONIC ACIDS
dc.subjectMPTP
dc.subjectIDENTIFICATION
dc.subjectACTIVATION
dc.subjectAPOPTOSIS
dc.subjectCASPASE-3
dc.subjectPERMEABILIZATION
dc.subjectDISRUPTION
dc.subjectANTICANCER
dc.title3-Pyridinylboronic acid normalizes the effects of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in zebrafish embryos
dc.typearticle
dspace.entity.typePublication
oaire.citation.titleDRUG AND CHEMICAL TOXICOLOGY

Files